Genetics in MedicineGenetic & Genomic MedicinePeer-reviewed journal article
Structural mapping of GABRB3 variants reveals genotype-phenotype correlation
Katrine M. JohanneseniD, Sumaiya IqbaliD, Milena Guazzi, Nazanin A. MohammadiiD, Eduardo Pérez‐PalmaiD, Élise SchaeferiD, Anne de Saint MartiniD, Marie Therese Abiwarde, Amy McTagueiD, Roser Maria PonsiD, Amélie PitoniD, Manju A. KurianiD, Gautam AmbegaonkariD, Helen V. FirthiD, Alba Sanchis‐JuaniD, Marie Deprez, Katrien JanseniD, Liesbeth De WaeleiD, Eva H. BrilstraiD, Nienke E. Verbeek, Marjan J. A. van Kempen, Walid FazeliiD, Pasquale StrianoiD, Federico ZaraiD, Gerhard H. VisseriD, , Elena GardellaiD
Abstract
PurposePathogenic variants in GABRB3 have been associated with a spectrum of phenotypes from severe developmental disorders and epileptic encephalopathies to milder epilepsy syndromes and mild intellectual disability. In the present study, we analyzed a large cohort of individuals with GABRB3 variants to deepen the phenotypic understanding and investigate genotype-phenotype correlations. MethodsThrough an international collaboration, we analyzed electro-clinical data of unpublished individuals with variants in GABRB3 and we reviewed previously published cases. All missense variants were mapped onto the 3D structure of the GABRB3 subunit and clinical phenotypes associated with the different key structural domains were investigated. ResultsWe characterize 71 individuals with GABRB3 variants, including 22 novel subjects, expressing a wide spectrum of phenotypes. Interestingly, phenotypes correlated with structural locations of the variants. Generalized epilepsy, with a median age at onset of 10.5 months, and mild-to-moderate intellectual disability were associated with variants in the extracellular domain. Focal epilepsy with early onset (median: 2.75 months of age) and severe intellectual disability were associated with variants in the pore-lining helical transmembrane domain. ConclusionThese genotype/phenotype correlations will aid the genetic counseling and treatment of individuals affected by GABRB3-related disorders. Future studies may reveal whether functional differences underlie the phenotypic differences. Key pointsO_LIPathogenic variants in GABRB3 cause a wide range of phenotypes C_LIO_LIMissense variants in the ECD have generalized epilepsy with later onset and non-severe ID C_LIO_LIMissense variants in the TMD have focal epilepsy with early onset and severe ID C_LIO_LIBehavioral issues are common features of GABRB3 disease C_LIO_LIPrecision medicine approaches for GABRB3 disease is limited C_LI
- Citations
- 23
- FWCI
- 2.69
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pathogenic ultra-rare variants in SLC6A1, SLC6A11, GAD1 and GAD2 are new & recurrent GABAergic loci for GGE syndromes
Seo‐Kyung Chung, Kate V. Everett, … Mark I. Rees·medRxiv·Apr 1, 2025
- Structural analysis of pathogenic missense mutations in GABRA2 and identification of a novel de novo variant in the desensitization gate
Alba Sanchis‐Juan, Marcia Anahí Hasenahuer, … Frances Lucy Raymond·Molecular Genetics & Genomic MedicinePeer-reviewed·Apr 29, 2020
- The human GABAA receptor α4 subunit variant Ile114Asn linked to epilepsy impairs membrane expression with β3 and δ subunits
Draegan Watson, Cecilia M. Borghese, … Marcel P Goldschen-Ohm·bioRxiv·Apr 25, 2026
- Missense variants in GABAA receptor beta2 subunit disrupt receptor biogenesis and cause loss of function
Xi Chen, Yajuan Wang, Ting‐Wei Mu·bioRxiv·Mar 9, 2025
- Pathogenicity Prediction of GABAA Receptor Missense Variants
Y.-J. Wang, G. H. Vu, T. Mu·bioRxiv·Nov 14, 2023
- De novo missense variants in SLC32A1 cause a neurodevelopmental disorder with epilepsy due to impaired GABAergic neurotransmission
Konrad Platzer, Heinrich Sticht, … Sonja M. Wojcik·Annals of NeurologyPeer-reviewed·Aug 19, 2022